A more reliable diagnosis of preterm birth is one of the biggest unsolved problems in modern obstetrics. Pregnolia's approach is unique and ground-breaking: We work for a simple, reliable and easy to use diagnostic device to fight the burden of preterm birth.

Thanks to co-funding from the European Union we can develop a cost-effective, worldwide scalable solution.
Our vision is a new preterm birth screening test which will bring relief to doctors, mothers and new-born worldwide.


Below a list of scientific publications regarding the Pregnolia System and its prototypes

  • Badir et al., Cervical softening occurs early in pregnancy: characterization of cervical stiffness in 100 healthy women using the aspiration technique. Prenatal Diagnosis 2013, 33, 737–741.
    See the publication here.

  • Badir et al., Objective assessment of cervical stiffness after administration of misoprostol for intrauterine contraceptive insertion. Ultrasound Int Open 2016; 02(02): E63-E67.
    See the publication here.

The Pregnolia System is currently used in the following clinical studies

  • SoftCervix: biomechanical based prediction of preterm delivery. See the information about the study here.

  • ATOPS: mechanical environment pregnancy with short cervix. See the information about the study here.

  • Cervical stiffness measurement in cervical insufficiency. See the information about the study here.


Feedback from first established doctor using the Pregnolia measurement device:

«The diagnosis of preterm birth in the low risk population, allowing timely initiation of therapy, is THE unsolved problem in modern obstetrics. We want to offer the Pregnolia System to our patients in order to know who is at risk, and for the best care possible.»

Dr. Bettina von Seefried, Owner of Gyn Health GmbH Zürich

EU Horizon information

Pregnolia has been awarded a SME Instrument Phase 2 Grant of € 1.28 million. The grant is used to improve the manufacturability of the diagnostic device for the preterm birth risk assessment and to perform activities towards commercial readiness.

Read the interview of Sabrina Badir here.

The project runs from September 2019 to August 2021.

Project details can be found here.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 873553.

«A diagnostic medical device determining the risk of premature birth - Pregnolia»

© 2020 by Pregnolia | Datenschutz